134 related articles for article (PubMed ID: 36806616)
21. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD
BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906
[TBL] [Abstract][Full Text] [Related]
22. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation.
McSweeney B; Allegretti JR; Fischer M; Xu H; Goodman KJ; Monaghan T; McLeod C; Mullish BH; Petrof EO; Phelps EL; Chis R; Edmison A; Juby A; Ennis-Davis R; Roach B; Wong K; Kao D
Gut Microbes; 2020; 11(1):51-62. PubMed ID: 31122134
[TBL] [Abstract][Full Text] [Related]
23. Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients.
Terveer EM; van Gool T; Ooijevaar RE; Sanders IMJG; Boeije-Koppenol E; Keller JJ; Bart A; Kuijper EJ;
Clin Infect Dis; 2020 Dec; 71(10):2630-2636. PubMed ID: 31728525
[TBL] [Abstract][Full Text] [Related]
24. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection.
Kim KO; Schwartz MA; Lin OST; Chiorean MV; Gluck M
Adv Ther; 2019 Aug; 36(8):2052-2061. PubMed ID: 31154629
[TBL] [Abstract][Full Text] [Related]
25. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
[TBL] [Abstract][Full Text] [Related]
26. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
[TBL] [Abstract][Full Text] [Related]
27. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
[TBL] [Abstract][Full Text] [Related]
28. Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.
Mehta N; Wang T; Friedman-Moraco RJ; Carpentieri C; Mehta AK; Rouphael N; Dhere T; Larsen CP; Kraft CS; Woodworth MH
J Clin Microbiol; 2022 Feb; 60(2):e0016121. PubMed ID: 34133889
[TBL] [Abstract][Full Text] [Related]
29. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study.
Ianiro G; Bibbò S; Masucci L; Quaranta G; Porcari S; Settanni CR; Lopetuso LR; Fantoni M; Sanguinetti M; Gasbarrini A; Cammarota G
Dig Liver Dis; 2020 Dec; 52(12):1390-1395. PubMed ID: 33004295
[TBL] [Abstract][Full Text] [Related]
30. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
Allegretti JR; Kassam Z; Chan WW
Dig Dis Sci; 2018 Jan; 63(1):193-197. PubMed ID: 29188472
[TBL] [Abstract][Full Text] [Related]
31. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
[TBL] [Abstract][Full Text] [Related]
32. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
33. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
[TBL] [Abstract][Full Text] [Related]
34. [Association between the clinical efficacy of fecal microbiota transplantation in recipients and the choice of donor].
Chen QY; Yang B; Tian HL; Lin ZL; Zhao D; Ye C; Zhang XY; Qin HL; Li N
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):69-76. PubMed ID: 32594729
[No Abstract] [Full Text] [Related]
35. Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank.
Seo HS; Chin HS; Kim YH; Moon HS; Kim K; Nguyen LP; Yong D
Ann Lab Med; 2021 Jul; 41(4):424-428. PubMed ID: 33536363
[TBL] [Abstract][Full Text] [Related]
36. [Fecal microbiota transplantation: indications, risks and opportunities].
Stallmach A; Steube A; Stallhofer J; Grunert PC; Merkel U; Hartmann M
Inn Med (Heidelb); 2022 Oct; 63(10):1036-1042. PubMed ID: 36053300
[TBL] [Abstract][Full Text] [Related]
37. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
Galpérine T; Engelmann I; Hantz S; Postil D; Dewilde A; Deplanque D; Martin R; Labreuche J; Lazrek M; Somers S; Ribot E; Alain S
PLoS One; 2023; 18(6):e0287847. PubMed ID: 37384665
[TBL] [Abstract][Full Text] [Related]
39. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.
Cammarota G; Ianiro G; Kelly CR; Mullish BH; Allegretti JR; Kassam Z; Putignani L; Fischer M; Keller JJ; Costello SP; Sokol H; Kump P; Satokari R; Kahn SA; Kao D; Arkkila P; Kuijper EJ; Vehreschild MJG; Pintus C; Lopetuso L; Masucci L; Scaldaferri F; Terveer EM; Nieuwdorp M; López-Sanromán A; Kupcinskas J; Hart A; Tilg H; Gasbarrini A
Gut; 2019 Dec; 68(12):2111-2121. PubMed ID: 31563878
[TBL] [Abstract][Full Text] [Related]
40. Assuring safety of fecal microbiota transplantation in the COVID-19 era: A single-center experience.
Chang TE; Lee KC; Lee PC; Wang YP; Lin YT; Huang HC; Luo JC; Ho HL; Huang YH; Hou MC;
JGH Open; 2023 Nov; 7(11):765-771. PubMed ID: 38034050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
